Try our beta test site
2 studies found for:    18565894 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Investigation of 68Ga-DOTATATE, as a PET Imaging Agent in Neuroendocrine Tumor Patients
Condition: Neuroendocrine Carcinoma
Intervention: Drug: 68Ga-DOTATATE
2 Recruiting Asymptomatic Small Pancreatic Endocrine Neoplasms.
Condition: Non Functioning Pancreatic Endocrine Tumor
Interventions: Diagnostic Test: Radiological imaging studies;   Other: Quality of Life Assessment

Study has passed its completion date and status has not been verified in more than two years.